Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
Historia
10
Métodos estadísticos
7
Ensayos clínicos
6
Investigaciones
6
Metodología
6
Pruebas clínicas
5
Práctica de juicios
5
Blues (Música)
3
Cáncer
3
Ensayos clinicos
3
Administración de justicia
2
Asesinato
2
Biografía
2
Civilización
2
Delitos políticos
2
Derecho
2
Diseño de investigación
2
Estados Unidos
2
Estadística
2
Evolución (Biología)
2
Libretos para óperas
2
Literatura inglesa
2
Medicina
2
Novela alemana
2
Novela estadounidense
2
Novela inglesa
2
Oncología
2
Orientación profesional
2
Política y gobierno
2
Quimioterapia
2
-
342581por Poublon, Nathan, Chidi, Ibtissam, Bethlehem, Martijn, Kuipers, Ellen, Gadiot, Ralph, Emous, Marloes, van Det, Marc, Dunkelgrun, Martin, Biter, Ulas, Apers, Jan“…To substantiate these findings, further research from prospective randomized controlled trials is needed.…”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
342582por Benning, Lorie, Mantsios, Andrea, Kerrigan, Deanna, Coleman, Jenell S., Golub, Elizabeth, Blackstock, Oni, Konkle-Parker, Deborah, Philbin, Morgan, Sheth, Anandi, Adimora, Adaora A., Cohen, Mardge H., Seidman, Dominika, Milam, Joel, Kassaye, Seble G., Taylor, Tonya, Murray, Miranda“…BACKGROUND: Long-acting (LA) injectable antiretroviral therapy (ART) has been found non-inferior to daily oral ART in Phase 3 trials. LA ART may address key barriers to oral ART adherence and be preferable to daily pills for some people living with HIV. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
342583por Lowrey, Catherine R., Blazevski, Benett, Marnet, Jean-Luc, Bretzke, Helen, Dukelow, Sean P., Scott, Stephen H.“…Interestingly, ICC values for Discrimination Threshold increased to 0.90 [0.77–0.96] (good to excellent) when the number of trials was reduced to the first 50. Most APM parameters had ICC’s above 0.80, (range, ICC = [0.86–0.88]) with the exception of variability (ICC = 0.30). …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
342584por Stawicki, Stanislaw P, Jeanmonod, Rebecca, Miller, Andrew C, Paladino, Lorenzo, Gaieski, David F, Yaffee, Anna Q, De Wulf, Annelies, Grover, Joydeep, Papadimos, Thomas J., Bloem, Christina, Galwankar, Sagar C, Chauhan, Vivek, Firstenberg, Michael S., Di Somma, Salvatore, Jeanmonod, Donald, Garg, Sona M, Tucci, Veronica, Anderson, Harry L, Fatimah, Lateef, Worlton, Tamara J, Dubhashi, Siddharth P, Glaze, Krystal S, Sinha, Sagar, Opara, Ijeoma Nnodim, Yellapu, Vikas, Kelkar, Dhanashree, El-Menyar, Ayman, Krishnan, Vimal, Venkataramanaiah, S, Leyfman, Yan, Saoud Al Thani, Hassan Ali, WB Nanayakkara, Prabath, Nanda, Sudip, Cioè-Peña, Eric, Sardesai, Indrani, Chandra, Shruti, Munasinghe, Aruna, Dutta, Vibha, Dal Ponte, Silvana Teixeira, Izurieta, Ricardo, Asensio, Juan A, Garg, Manish“…As the race to develop an effective vaccine intensifies, several clinical trials of antivirals and immune modulators are underway, though no reliable COVID-19-specific therapeutics (inclusive of some potentially effective single and multi-drug regimens) have been identified as of yet. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
342585por DiBenedetti, Dana B., Slota, Christina, Wronski, Samantha L., Vradenburg, George, Comer, Meryl, Callahan, Leigh F., Winfield, John, Rubino, Ivana, Krasa, Holly B., Hartry, Ann, Wieberg, Dan, Kremer, Ian N., Lappin, Debra, Martin, Allison D., Frangiosa, Terry, Biggar, Virginia, Hauber, Brett“…Neuropsychological assessments traditionally used in AD clinical trials may not evaluate the often-subtle concepts that are important to patients and care partners. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
342586por Baldomero, Arianne K., Wendt, Chris H., Petersen, Ashley, Gaeckle, Nathaniel T., Han, MeiLan K., Kunisaki, Ken M.“…The magnitude of the differences was clinically small, but given the high prevalence of GERD, further investigation is warranted to understand the potential disease-modifying role of GERD in COPD pathogenesis and progression. CLINICAL TRIALS REGISTRATION: NCT00608764.…”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
342587por Combes, Alain, Auzinger, Georg, Capellier, Gilles, du Cheyron, Damien, Clement, Ian, Consales, Guglielmo, Dabrowski, Wojciech, De Bels, David, de Molina Ortiz, Francisco Javier González, Gottschalk, Antje, Hilty, Matthias P., Pestaña, David, Sousa, Eduardo, Tully, Redmond, Goldstein, Jacques, Harenski, Kai“…Further evidence from randomised clinical trials and/or high-quality prospective studies is needed to better guide decision making.…”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
342588por Noibi, Saeed, Mohy, Ahmed, Gouhar, Raef, Shaker, Fadel, Lukic, Tamara, Al-Jahdali, Hamdan“…Evaluation of studies focused on randomised controlled trials (RCTs). In both reviews, initial (January 2018) and updated (November 2019) searches were conducted in EMBASE and PubMed databases. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
342589por Mowry, Ellen M., Bermel, Robert A., Williams, James R., Benzinger, Tammie L. S., de Moor, Carl, Fisher, Elizabeth, Hersh, Carrie M., Hyland, Megan H., Izbudak, Izlem, Jones, Stephen E., Kieseier, Bernd C., Kitzler, Hagen H., Krupp, Lauren, Lui, Yvonne W., Montalban, Xavier, Naismith, Robert T., Nicholas, Jacqueline A., Pellegrini, Fabio, Rovira, Alex, Schulze, Maximilian, Tackenberg, Björn, Tintore, Mar, Tivarus, Madalina E., Ziemssen, Tjalf, Rudick, Richard A.“…Those with relapsing–remitting MS demonstrated more demographic heterogeneity than the participants in six randomized phase 3 MS treatment trials. Across sites, a significant variation was observed in the follow-up frequency and the patterns of disease-modifying therapy use. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
342590por Wei, Rong, Wang, Ziyue, Zhang, Yaping, Wang, Bin, Shen, Ningning, E, Li, Li, Xin, Shang, Lifang, Shang, Yangwei, Yan, Wenpeng, Zhang, Xiaoqin, Ma, Wenxia, Wang, Chen“…However, more detailed experiments and clinical trials are needed to verify their drug targets role in clinical medical use.…”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
342591por Ma, Jialin, Yan, Zheng, Zhang, Jiuyang, Zhou, Wenping, Yao, Zhihua, Wang, Haiying, Chu, Junfeng, Yao, Shuna, Zhao, Shuang, Zhang, Peipei, Xu, Yuanlin, Xia, Qingxin, Ma, Jie, Wei, Bing, Yang, Shujun, Liu, Kangdong, Guo, Yongjun, Liu, Yanyan“…These findings warrant the development of optimal alternative treatment in clinical trials.…”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
342592por Lu, Chun-Yi, Chung, Ching-Hu, Huang, Li-Min, Kruger, Eliza, Tan, Seng-Chuen, Zhang, Xu-Hao, Chiu, Nan-Chang“…In addition to S. pneumoniae, clinical trials suggest efficacy of PHiD-CV against NTHi AOM. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
342593por Feng, Hai, Chen, Xueming, Guo, Xiaobo, Zhang, Zhe, Zhang, Zhiwen, Liu, Bin, Lian, Lishan“…METHODS: Electronic databases were searched to identify randomized controlled trials (RCTs) that compared DEB and UCB till November 2018. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
342594por Ferguson, Gary T., Darken, Patrick, Ballal, Shaila, Siddiqui, Mohd Kashif, Singh, Barinder, Attri, Sumeet, Holmgren, Ulf, de Nigris, Enrico“…METHODS: A systematic literature review was conducted to identify randomized controlled trials of at least 10-week duration, including at least one fixed-dose or open combination triple therapy arm, in patients with moderate to very severe COPD. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
342595por Bonaventura, Klaus, Schwefer, Markus, Yusof, Ahmad Khairuddin Mohamed, Waliszewski, Matthias, Krackhardt, Florian, Steen, Philip, Ocaranza, Raymundo, Zuhdi, Ahmad Syadi, Bang, Liew Houng, Graf, Kristof, Böck, Ulrich, Chin, Kenneth“…The primary endpoint was the target lesion failure (TLF) rate at 9 months (ClinicalTrials.gov Identifier NCT02554292). RESULTS: A total of 481 patients (496 lesions) were recruited to treat de novo lesions (78.4%, 377), BMS-ISR (4.0%, 19), and DES-ISR (17.6%, 85). …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
342596“…BACKGROUND: The indoleamine 2, 3-dioxygenase (IDO) inhibitor 1-methyl-tryptophan (1-MT) is currently being used in clinical trials in patients with relapsed or refractory solid tumors by inhibiting tumor immune escape. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
342597por Mesnier, Jules, Cottin, Yves, Coste, Pierre, Ferrari, Emile, Schiele, François, Lemesle, Gilles, Thuaire, Christophe, Angoulvant, Denis, Cayla, Guillaume, Bouleti, Claire, Gallet de Saint Aurin, Romain, Goube, Pascal, Lhermusier, Thibault, Dillinger, Jean-Guillaume, Paganelli, Franck, Saib, Anis, Prunier, Fabrice, Vanzetto, Gerald, Dubreuil, Olivier, Puymirat, Etienne, Boccara, Franck, Eltchaninoff, Hélène, Cachanado, Marine, Rousseau, Alexandra, Drouet, Elodie, Steg, Philippe-Gabriel, Simon, Tabassome, Danchin, Nicolas“…The FRENCHIE cohort is registered with ClinicalTrials.gov, NCT04050956. FINDINGS: Between Feb 17 and April 12, 2020, 1167 patients were consecutively admitted within 48 h of acute myocardial infarction (583 with STEMI, 584 with NSTEMI) and were included in the study. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
342598por Robène, Isabelle, Maillot-Lebon, Véronique, Chabirand, Aude, Moreau, Aurélie, Becker, Nathalie, Moumène, Amal, Rieux, Adrien, Campos, Paola, Gagnevin, Lionel, Gaudeul, Myriam, Baider, Claudia, Chiroleu, Fréderic, Pruvost, Olivier“…Their reliability was evidenced through numerous trials on a wide range of bacterial strains and plant samples. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
342599por Gardner, William, Nicholls, Stuart G., Reid, Graham J., Hutton, Brian, Hamel, Candyce, Sikora, Lindsey, Salamatmanesh, Mina, Duncan, Laura, Georgiades, Katholiki, Gilliland, Jason“…METHODS: The following databases will be searched: Medline, Embase, PsycINFO, Cochrane Controlled Register of Trials, CINAHL, EconLit, and Sociological Abstracts. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
342600por Yilmaz, Musa, Alfayez, Mansour, DiNardo, Courtney D., Borthakur, Gautam, Kadia, Tapan M., Konopleva, Marina Y., Loghavi, Sanam, Kanagal-Shamanna, Rashmi, Patel, Keyur P., Jabbour, Elias J., Garcia-Manero, Guillermo, Pemmaraju, Naveen, Pierce, Sherry A., Ghayas, Issa, Short, Nicholas J., Montalban-Bravo, Guillermo, Takahashi, Koichi, Assi, Rita, Alotaibi, Ahmad S., Ohanian, Maro, Andreeff, Michael, Cortes, Jorge E., Kantarjian, Hagop M., Ravandi, Farhad, Daver, Naval G.“…BACKGROUND: Second-generation FLT3-inhibitors (FLT3i) demonstrated single-agent composite CR rates (CRc) of 45–55% in patients with relapsed/refractory (R/R) FLT3-mutated AML in phase II/III trials. However, > 85% of patients treated were prior FLT3i naïve. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto